阚亚柏,韩战营,王徐乐

• 1:郑州大学第一附属医院心血管内科

摘要(Abstract)：

<正>急诊经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)策略作为ST段抬高型心肌梗死(STelevation myocardial inf arction,STEMI)再灌注治疗的重要方式,与溶栓治疗相比能够明显改善临床预后~([1-4])。无论是裸金属支架(bare-metal stents,BMS)置入术还是药物洗脱支架(drug-eluting stents,DES)置入术,与早期

关键词(KeyWords)： 药物涂层球囊;ST段抬高型心肌梗死;经皮冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 阚亚柏,韩战营,王徐乐

参考文献(References)：

• [1]Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy f or acute myocardial infarction:a quantitative review of 23 randomised trials.Lancet,2003,361(9351):13-20.
• [2]Zijlstra F,Hoorntje JC,de Boer MJ,,et al.Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.N Engl J Med,1999(19),341:1413-1419.
• [3]Zijlstra F,de Boer MJ,Hoorntje JC,et al.A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.N Engl J Med,1993,328(10):680-684.
• [4]Stone GW,Grines CL,Browne KF,et al.Predictors of inhospital and 6-month outcome after acute myocardial infarction in the reperf usion era:the Primary Angioplasty in Myocardial Infarction(PAMI)trial.J Am Coll Cardiol,1995,25(2):370-377.
• [5]Grines CL,Cox DA,Stone GW,et al.Coronary angioplasty with or without stent implantation for acute myocardial infarction.Stent Primary Angioplasty in Myocardial Infarction Study Group.N Engl J Med,1999,341(26):1949-1956.
• [6]Cox DA,Stone GW,Grines CL,et al.Outcomes of optimal or“stent-like”balloon angioplasty in acutemyocardial infarction:the CADILLAC trial.J Am Coll Cardiol,2003,42(6):971-977.
• [7]Suh HS,Song HJ,Choi JE,et al.Drug-eluting stents versus baremetal stents in acute myocardial infarction:A systemtic review and meta-analysis.Int J Technol Assess Health Care,2011,27(1):11-22.
• [8]Stone GW,Grines CL,Cox DA,et al.Comparison of angioplasty with stenting,with or without abciximab,in acute myocardial infarction.N Engl J Med,2002,346(13):957-966.
• [9]Brott BC,Anayiotos AS,Chapman GD,et al.Severe,diffuse coronary artery spasm after drug-eluting stent placement.J Invasive Cardiol,2006,18(12):584-592.
• [10]Nakamura T,Brott BC,Brants I,et al.Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model.JACC Cardiovasc Interv,2011,4(2):247-255.
• [11]Degertekin M,Serruys PW,Tanabe K.Long-term followup of incomplete stent apposition in patients who received the sirolimus-eluting stent for de novo coronary lesions:An intravascular ultrasound analysis.Circulation,2003,108(22):2747-2750.
• [12]Mc Fadden EP,Stabile E,Regar E,et al.Late thrombosis in drugeluting coronary stents after discontinuation of antiplatelet therapy.Lancet,2004,364(9444):1519-1521.
• [13]Nakazawa G,Finn AV,Joner M,et al.Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients:an autopsy study.Circulation,2008,118(11):1138-1145.
• [14]Stone SG,Serrao GW,Mehran R,et al.Incidence,predictors,and implications of reinfarction af ter primary percutaneous coronary intervention in ST-segment-elevation myocardial inf arction:the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial.Circ Cardiovasc Interv,2014,7(4):543-551.
• [15]Vink MA,Dirksen MT,Suttorp MJ,et al.5-year followup after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute STsegment elevation myocardial infarction:a follow-up study of the PASSION(Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation)trial.JACC Cardiovasc Interv,2011,4(1):24-29.
• [16]Posa A,Nyolczas N,Hemetsberger R,et al.Optimization of drug-eluting balloon use for safety and efficacy:evaluation of the2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries.Catheter Cardiovasc Interv,2010,76(3):395-403.
• [17]Scheller B,Hehrlein C,Bocksch W,et al.Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.Clin Res Cardiol,2008,97(10):773-781.
• [18]Unverdorben M,Vallbracht C,Cremers B,et al.Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.Circulation,2009,119:2986-94.
• [19]Unverdorben M,Kleber FX,Heuer H,et al.Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.Clin Res Cardiol,2010,99(23):165-174.
• [20]Acampora KB,Nagatomi J,Langan EM,3rd,et al.Increased synthetic phenotype behavior of smooth muscle cells in response to in vitro balloon angioplasty injury model.Ann Vasc Surg,2010,24(1):116-126.
• [21]Stone GW,Ellis SG,Cox DA.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease.N Engl J Med,2004,350(3):221-231.
• [22]Belkacemi A,Agostoni P,Nathoe HM,et al.First results of the DEB-AMI(drug eluting balloon in acute ST-segment elevation myocardial infarction)trial:a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic,intravascular,functional,and clinical outcomes.J Am Coll Cardiol,2012,59(25):2327-2337.
• [23]Vos NS,Dirksen MT,Vink MA,et al.Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam(PAPPA):one-year clinical outcome of a pilot study.Euro Intervention,2014,10(5):584-590.
• [24]Nijhoff F,Agostoni P,Belkacemi A,et al.Primary percutaneous coronary intervention by drug-eluting balloon angioplasty:the nonrandomized fourth arm of the DEB-AMI(drug-eluting balloon in ST-segment elevation myocardial infarction)trial.Catheter Cardiovasc Interv,2015,Suppl 1:S34-S44.
• [25]Ho HH,Tan J,Ooi YW,et al.Preliminary experience with drugcoated balloon angioplasty in primary percutaneous coronary intervention.World J Cardiol,2015,7(6):311-314.
• [26]Gobi? D,Tomuli? V,Luli?D,et al.Drug Coated Balloon Versus Drug Eluting Stent in Primary Percutaneous Coronary Intervention:A Feasibility Study.Am J Med Sci,2017,354(6):553-560